Deep sequencing of MYC DNA-Binding sites in Burkitt lymphoma

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Seitz, Volkhard ^a   Butzhammer, Peter ^b   Hirsch, Burkhard ^a   Hecht, Jochen ^a   Gütgemann, Ines ^c   Ehlers, Anke ^a   Lenze, Dido ^a   Oker, Elisabeth ^a   Sommerfeld, Anke ^a   von der Wall, Edda ^a   König, Christoph ^d   Zinser, Christian ^e   Spang, Rainer ^b   Hummel, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d German Genome Resource Center RZPD   (Germany)

^e Genomatix GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE METHYLTRANSFERASE; MYC PROTEIN; SMALL INTERFERING RNA; DNA; MYC PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; B LYMPHOCYTE; BINDING SITE; BIOGENESIS; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; RIBOSOME; UPREGULATION; DNA MICROARRAY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; METABOLISM; TUMOR CELL CULTURE;

BINDING SITES; BURKITT LYMPHOMA; CHROMATIN IMMUNOPRECIPITATION; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 80755159547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026837     Document Type: Article

References (53)

1. Klapproth K, Wirth T, (2010) Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol.
2. Oster SK, Ho CS, Soucie EL, Penn LZ, (2002) The myc oncogene: MarvelouslY Complex. Adv Cancer Res 84: 81-154.
3. Knoepfler PS, (2007) Myc goes global: new tricks for an old oncogene. Cancer Res 67: 5061-5063.
4. Felsher DW, Bishop JM, (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4: 199-207.
5. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, et al. (2003) MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4: 575-580.
6. Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, et al. (2003) Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 4: 484-490.
7. Liu X, Tesfai J, Evrard YA, Dent SY, Martinez E, (2003) c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J Biol Chem 278: 20405-20412.
8. Saunders A, Core LJ, Lis JT, (2006) Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol 7: 557-567.
9. Eberhardy SR, Farnham PJ, (2001) c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem 276: 48562-48571.
10. Gartel AL, Shchors K, (2003) Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 283: 17-21.
11. Brenner C, Deplus R, Didelot C, Loriot A, Vire E, et al. (2005) Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J 24: 336-346.
12. Rottmann S, Luscher B, (2006) The Mad side of the Max network: antagonizing the function of Myc and more. Curr Top Microbiol Immunol 302: 63-122.
13. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, et al. (2006) The c-Myc target gene network. Semin Cancer Biol 16: 253-264.
14. Cowling VH, Cole MD, (2006) Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 16: 242-252.
15. Bui TV, Mendell JT, (2010) Myc: Maestro of MicroRNAs. Genes Cancer 1: 568-575.
16. Boxer LM, Dang CV, (2001) Translocations involving c-myc and c-myc function. Oncogene 20: 5595-5610.
17. Hecht JL, Aster JC, (2000) Molecular biology of Burkitt's lymphoma. J Clin Oncol 18: 3707-3721.
18. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon IARC.
19. Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, et al. (2011) The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia (Epub, ahead of print).
20. Chapman CJ, Wright D, Stevenson FK, (1998) Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis. Leuk Lymphoma 30: 257-267.
21. Isobe K, Tamaru J, Nakamura S, Harigaya K, Mikata A, et al. (2002) VH gene analysis in sporadic Burkitt's lymphoma: somatic mutation and intraclonal diversity with special reference to the tumor cells involving germinal center. Leuk Lymphoma 43: 159-164.
22. Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, et al. (2005) Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106: 1031-1036.
23. Li Z, Van CS, Qu C, Cavenee WK, Zhang MQ, et al. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100: 8164-8169.
24. Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, et al. (2006) Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA 103: 17834-17839.
25. Hawkins RD, Hon GC, Ren B, (2010) Next-generation genomics: an integrative approach. Nat Rev Genet 11: 476-486.
26. Lee TI, Johnstone SE, Young RA, (2006) Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 1: 729-748.
27. Bookout AL, Mangelsdorf DJ, (2003) Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1: e012.
28. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
29. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
30. Anders S, Huber W, (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
31. Zhu LJ, Gazin C, Lawson ND, Pages H, Lin SM, et al. (2010) ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11: 237.
32. Weigelt K, Moehle C, Stempfl T, Weber B, Langmann T, (2008) An integrated workflow for analysis of ChIP-chip data. Biotechniques 45: 131-140.
33. Wolfertstetter F, Frech K, Herrmann G, Werner T, (1996) Identification of functional elements in unaligned nucleic acid sequences by a novel tuple search algorithm. Comput Appl Biosci 12: 71-80.
34. Hirsch B, Hummel M, Bentink S, Fouladi F, Spang R, et al. (2008) CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. Am J Pathol 172: 510-520.
35. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M, (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1): S96-104.
36. Smyth GK, (2005) Bioinformatics and Computational Biology Solutions using R and Bioconductor; In: Gentleman R, Dudoit S, Irizarry R, Huber W, editors. New York Springer.
37. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
38. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
39. Huang dW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
40. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
41. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, et al. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
42. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
43. Baker LA, Allis CD, Wang GG, (2008) PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat Res 647: 3-12.
44. Sauvageau M, Sauvageau G, (2010) Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 7: 299-313.
45. Liu YC, Li F, Handler J, Huang CR, Xiang Y, et al. (2008) Global regulation of nucleotide biosynthetic genes by c-Myc. PLos One 3: e2722.
46. Dai MS, Lu H, (2008) Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 105: 670-677.
47. Brown SJ, Cole MD, Erives AJ, (2008) Evolution of the holozoan ribosome biogenesis regulon. BMC Genomics 9: 442.
48. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, et al. (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13: 2678-2690.
49. Haupt Y, Bath ML, Harris AW, Adams JM, (1993) bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 8: 3161-3164.
50. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV, (2003) An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 4: R69.
51. Vallespinos M, Fernandez D, Rodriguez L, Alvaro-Blanco J, Baena E, et al. (2011) B Lymphocyte Commitment Program Is Driven by the Proto-Oncogene c-myc. J Immunol 186: 6726-6736.
52. Fan J, Zeller K, Chen YC, Watkins T, Barnes KC, et al. (2010) Time-dependent c-Myc transactomes mapped by Array-based nuclear run-on reveal transcriptional modules in human B cells. PLoS One 5: e9691.
53. God JM, Haque A, (2010) Burkitt lymphoma: pathogenesis and immune evasion. J Oncol Epub 2010 Oct 5.